Document is current
Any future updates will be listed below
-
Authors
Li, Lili
Ha, Taekyu
Feng, Jing-Xin https://orcid.org/0000-0003-0677-2792
DiPrima, Michael
Wang, Dunrui
Jailwala, Parthav https://orcid.org/0000-0002-2943-801X
Meyer, Thomas https://orcid.org/0000-0002-7185-5597
Lack, Justin
Ohnuki, Hidetaka
Tosato, Giovanna https://orcid.org/0000-0003-1663-3227
- License Information
-
More Information
Article History
Received: 31 December 2025
Revised: 12 March 2026
Accepted: 25 March 2026
First Online: 10 April 2026
Competing interests
: This research was fully supported by the Intramural Program of the NCI/CCR. G.T. reports research support from Celgene (now Bristol Myers Squibb) and Amgen; and is a coinventor on patents or patent applications related to internalization of target receptors, epigenetic analysis, and ephrin tyrosine kinase inhibitors. All rights, title, and interest to these patents have been assigned to the US Department of Health and Human Services. No other disclosures by the Authors.
: All animal experiments were approved by the Institutional Animal Care and Use Committee of the Center for Cancer Research (CCR, Bethesda, MD), NCI, NIH, and were conducted according to the NIH Guide for the Care and Use of Laboratory Animals (National Academies Press, 2011).
